Under construction – not a live service
Sign in
Taking people in FranceNo phase

Biobank of blood samples from people with arthritis or osteoporosis

Collects blood samples from adults with rheumatoid arthritis, spondyloarthritis, psoriatic arthritis or osteoporosis.

Plain-language title generated from the registry record
Registry title: Biobank for Inflammatory Chronic Diseases and Osteoporosis

Key facts

Where
Toulouse, FranceSee the site

Could this be for you?

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 99 years old?

Source: NCT05039216, who can take part

Where in France

  • Purpan University HospitalToulouse, FranceTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
University Hospital, Toulouse
Trial code
NCT05039216
Record updated
19 March 2026
Original description
The aim of this study is to constitute a biobank for patients followed in the Rheumatology center of Toulouse University Hospital for a chronic inflammatory rheumatism including rheumatoid arthritis (RA), spondyloarthritis(SpA), and psoriatic arthritis (PsA) or a chronic bone disease including osteoporosis in order to identify biomarkers associated with therapeutic response.Read full original descriptionShow less

Biobank for Inflammatory Chronic Diseases and Osteoporosis of TOULouse

The aim of this study is to constitute a biobank for patients followed in the Rheumatology center of Toulouse University Hospital for a chronic inflammatory rheumatism including rheumatoid arthritis (RA), spondyloarthritis(SpA), and psoriatic arthritis (PsA) or a chronic bone disease including osteoporosis in order to identify biomarkers associated with therapeutic response.

Inclusion: Chronic inflammatory rheumatism including RA, SpA or PsA or patients with primary or secondary osteoporosis; With National Health Assurance; Able to consent to the study.

Exclusion: Pregnancy or breastfeeding; Not able to give a consent; Severe anemia (Hb<10g/L).

ClinicalTrials.gov NCT05039216